AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2025
Oct 28, 2025
30136_dirs_2025-10-28_fb42c963-b16e-450d-94ba-2a4a0126f02e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2025-10-27
Reporting Person: Farshchi Jamil (EVP, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-27 | Common Stock | M | 4925.0000 | $175.4800 | Acquired | 44289.0000 | Direct |
| 2025-10-27 | Common Stock | S | 4925.0000 | $238.9400 | Disposed | 39364.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | Stock Option/Right to Buy | $175.4800 | M | 4925.0000 | Disposed | 2026-02-21 | Common Stock (4925.0000) | Direct |
Footnotes
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 372 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.
F3: The option vested in three equal annual increments beginning 2/21/2021.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26